Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine

PHASE2CompletedINTERVENTIONAL
Enrollment

256

Participants

Timeline

Start Date

Not specified

Study Completion Date

March 31, 1998

Conditions
HIV Infections
Interventions
DRUG

Lamivudine

DRUG

Stavudine

DRUG

Zidovudine

DRUG

Didanosine

Trial Locations (32)

10003

Beth Israel Med. Ctr. (Mt. Sinai), New York

10016

NYU Med. Ctr., Dept. of Medicine, New York

14215

SUNY - Buffalo, Erie County Medical Ctr., Buffalo

19104

Hosp. of the Univ. of Pennsylvania CRS, Philadelphia

21287

Johns Hopkins Adult AIDS CRS, Baltimore

33136

Univ. of Miami AIDS CRS, Miami

43210

The Ohio State University Medical Center, Columbus

44109

MetroHealth CRS, Cleveland

46202

Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis

Methodist Hosp. of Indiana, Indianapolis

60612

Cook County Hosp. CORE Ctr., Chicago

Rush Univ. Med. Ctr. ACTG CRS, Chicago

60640

Weiss Memorial Hosp., Chicago

63112

St. Louis ConnectCare, Infectious Diseases Clinic, St Louis

80262

University of Colorado Hospital CRS, Aurora

90095

UCLA CARE Center CRS, Los Angeles

92103

Ucsd, Avrc Crs, San Diego

94115

Stanford CRS, Palo Alto

95128

Santa Clara Valley Med. Ctr., San Jose

96816

Queens Med. Ctr., Honolulu

Univ. of Hawaii at Manoa, Leahi Hosp., Honolulu

98122

University of Washington AIDS CRS, Seattle

Unknown

Alabama Therapeutics CRS, Birmingham

San Mateo County AIDS Program, San Mateo

Northwestern University CRS, Chicago

Beth Israel Deaconess Med. Ctr., ACTG CRS, Boston

Washington U CRS, St Louis

Univ. of Rochester ACTG CRS, Rochester

Unc Aids Crs, Chapel Hill

Carolinas HealthCare System, Carolinas Med. Ctr., Charlotte

Regional Center for Infectious Disease, Wendover Medical Center CRS, Greensboro

Puerto Rico-AIDS CRS, San Juan

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH